0001950047-23-005849.txt : 20231211 0001950047-23-005849.hdr.sgml : 20231211 20231211161818 ACCESSION NUMBER: 0001950047-23-005849 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AC Immune SA CENTRAL INDEX KEY: 0001651625 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37891 FILM NUMBER: 231478374 BUSINESS ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 BUSINESS PHONE: 41 21 345 91 21 MAIL ADDRESS: STREET 1: EPFL INNOVATION PARK, BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Pfeifer Andrea CENTRAL INDEX KEY: 0001697107 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AC IMMUNE SA STREET 2: EPFL INNOVATION PARK BUILDING B CITY: 1015 LAUSANNE STATE: V8 ZIP: 00000 144 1 primary_doc.xml 144 0001697107 XXXXXXXX LIVE 0001651625 AC IMMUNE SA 001-37891 EPFL INNOVATION PARK Building B 1015 Lausanne V8 00000 41213459121 ANDREA PFEIFER Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

20000 73800.00 83620364 12/11/2023 NASDAQ Common 06/01/2012 Series B Pref. shares Issuer N 20000 06/01/2012 N/A N 10b5-1 Sales for ANDREA PFEIFER

EPFL INNOVATION PARK Building B 1015 Lausanne V8 00000

Common 12/07/2023 5168 18901.96 10b5-1 Sales for ANDREA PFEIFER

EPFL INNOVATION PARK Building B 1015 Lausanne V8 00000

Common 12/06/2023 14832 53647.34 12/11/2023 03/31/2023 /s/ Andrea Pfeifer